Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" /
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Zach London on Twitter: "6/ Different heavy and light chains are associated with different malignancies. Get to know which with this handy chart. As for me, my heart beats a little faster
Monoclonals - an overview | ScienceDirect Topics
247 SPEP It Up - The Curbsiders
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Episode 040: Myeloma Series, Pt.1 - Intro to Testing and MGUS — The Fellow On Call